Oscar Health (OSCR) has been one of the stocks most watched by Zacks.com users lately. So, it is wor

HAS, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 30th, 202

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $30.79, denoting a +1.0

Oscar Health is broadening its growth beyond ACA insurance through Lucie and CHOICE, adding fee-base

E, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 28th, 2026.

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 26th, 20

Oscar Health, Inc. (OSCR) concluded the recent trading session at $30.99, signifying a -6.99% move f

Oscar Health (OSCR), a health insurer focused on the individual market, will enter South Carolina an

Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $33.47, representing a -2.48% chang

Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader mark

Oscar Health trades ~13% below its 2021 IPO price, even though management expects 2026 revenue at ~7

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13,52026.

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $34.32, indicating a +1.57%

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained str

Oscar Health's surging revenue, membership gains and improving profitability bolster its growth stor

Oscar Health raises its 2026 operating earnings outlook to $500M-$700M as pricing gains and tech eff

Oscar Health, Inc. OSCR shares have gained 14.9% in the past three months, outpacing the broader mar

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2026.

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price

Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted E

Oscar Health (NYSE:OSCR) held its second-quarter earnings conference call on Thursday. Below is the

Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises

B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Underperform and rai

Shares of Oscar Health are trading higher Thursday as Wall Street analysts raised price targets foll

Stephens & Co. analyst Raj Kumar reiterates Oscar Health (NYSE:OSCR) with a Equal-Weight and

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

As previously announced, Oscar Health, Inc. (the "Company" or "Oscar") will host its

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and rai

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p

Oscar Health (OSCR) beat Q2 earnings with $4.88B revenue, but shares fell on expected ACA membership

Oscar Health (NYSE:OSCR) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.70

     As of June 30, Effectuated Membership by Offering2026 2025 Individual and Small Group (1)2,963,

Oscar Health (NYSE:OSCR) reported quarterly earnings of $1.10 per share which beat the analyst conse

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a cons

Barclays analyst Andrew Mok upgrades Oscar Health (NYSE:OSCR) from Equal-Weight to Overweight and

Oscar Health shares reach fresh 52-week highs Wednesday, extending an 80% YTD rally after Monday&#39

Oscar Health shares surged after the company reaffirmed its 2026 outlook and provided a business upd

Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t